MedTrace Logo

Prospective Study of Fibrosis In the Lung Endpoints (PROFILE - Central England)

NCT01134822 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 330

Last updated 2018-10-15

No results posted yet for this study

Summary

The overall aim of this study is to develop a test that predicts the prognosis of IPF (Idiopathic Pulmonary Fibrosis) and which could be used to determine whether new treatments for IPF are likely to work.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Gisli Jenkins, Dr · University of Nottingham

  • Robert Berg, Dr · University Hospitals of Derby and Burton NHS Foundation Trust

  • Sanjay Agarwal, Dr · University Hospitals, Leicester

  • Moira White, Dr · Sheffield Teaching Hospitals NHS Foundation Trust

  • Khaled Amsha, Dr · Sherwood Forest Hospitals NHS Trust

  • David Thickett, Dr · University Hospital Birmingham NHS Foundation Trust

  • Uttam Nanda, Dr · Burton Hospitals NHS Foundation Trust

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2017-09-05
Completion
2017-09-05

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01134822 on ClinicalTrials.gov